
New survey confirms rare disease patients face mental health crisis but lack professional support, says leading biotech
SynaptixBio, the only company licensed to commercialise a treatment for the rare, deadly disease

SynaptixBio, the only company licensed to commercialise a treatment for the rare, deadly disease